This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Helmholtz Zentrum Munchen Deutsches Forschungszentrum Fur Gesundheit Und Umwelt, Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt Gmbh. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 94 
1 out of 15 Years Active: 2020-2025
Title: **Jara Kerstin Brenke: Pioneering Research in Pharmaceutical Innovations**
Introduction
Jara Kerstin Brenke is an accomplished inventor based in Munich, Germany, known for her significant contributions to the field of pharmaceutical research. With a focus on developing innovative treatments for various diseases, she has been awarded three patents that showcase her expertise and commitment to advancing healthcare solutions.
Latest Patents
Among Jara's latest innovations are her patents related to TRAF 6 inhibitors. These compounds are pivotal in the treatment of serious health conditions such as cancer, immune diseases, Parkinson's disease, cardiac hypertrophy, and Type-2 diabetes. The patents also encompass pharmaceutical compositions that include these compounds, as well as kits of parts that incorporate them, highlighting the practical applications of her research in medical therapies.
Career Highlights
Throughout her career, Jara has worked at the Helmholtz Zentrum München—Deutsches Forschungszentrum für Gesundheit und Umwelt, a leading research institution. Here, she has played an essential role in various projects aimed at addressing critical health issues through innovative pharmaceutical solutions. Her dedication to research and development in this field underscores her status as a prominent inventor.
Collaborations
Jara has collaborated with various talented professionals in her field, including Kamyar Hadian and Gerrit Juerjens. These partnerships have been instrumental in her ability to push the boundaries of scientific research and develop cutting-edge solutions that benefit society.
Conclusion
Jara Kerstin Brenke's contributions to pharmaceutical innovation continue to make a significant impact in the healthcare industry. Her work on TRAF 6 inhibitors exemplifies her commitment to addressing complex health challenges, paving the way for new and effective treatments. As she progresses in her career, her inventive spirit and collaborative efforts will undoubtedly lead to further breakthroughs in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile